4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001140361-10-045868
CIK 0001389545other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:26 PM ET
Size
6.0 KB
Accession
0001140361-10-045868
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2009-10-06+30,000→ 324,200 totalExercise: $1.75From: 2010-10-06Exp: 2019-10-06→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Original Form 4 filed on October 7, 2009. This amended form is being filed to correct the total securities following reported transaction under Table II, Item 9 which should be 324,200 not 124,200.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:26 PM ET
- Size
- 6.0 KB